ConductScience.org, home

Paper21069

Antipsychotic drugs: clinical pharmacology and therapeutic use.

Davis JM and 1 other. Drugs, 1977. Cited by 84 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antipsychotic drugs: clinical pharmacology and therapeutic use. Papers, record 21069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21069

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antipsychotic drugs: clinical pharmacology and therapeutic use.
PubMed
Journal
Drugs
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
3.81
iCite
Revised in PubMed
2024-08-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davis JMJ M
2Casper RR

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Psychotic DisordersMajor topic
Chlorpromazine
Clinical Trials as Topic
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Drug Hypersensitivity
Drug Therapy, Combination
Dyskinesia, Drug-Induced
Hemodynamics
Humans
Recurrence
Schizophrenia

Source PubMed

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,498,342A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients.J Clin Exp Psychopathol Q Rev Psychiatry Neurol1961https://conductscience.org/library/papers/14498342PubMed
24,948,596Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.Behav Neuropsychiatry1971https://conductscience.org/library/papers/4948596PubMed
314,270,524CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT.Br J Psychiatry1965https://conductscience.org/library/papers/14270524PubMed
44,571,196Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.Br Med J1973https://conductscience.org/library/papers/4571196PubMed
51,097,221Loxapine succinate: a controlled double-blind study in chronic schizophrenia.Dis Nerv Syst1975https://conductscience.org/library/papers/1097221PubMed
64,629,112A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.Curr Ther Res Clin Exp1972https://conductscience.org/library/papers/4629112PubMed
713,859,388A study of phenothiazines with male and female chronically ill schizophrenic patients.J Nerv Ment Dis1962https://conductscience.org/library/papers/13859388PubMed
84,589,978Evaluation of loxapine succinate in chronic schizophrenia.Dis Nerv Syst1972https://conductscience.org/library/papers/4589978PubMed
91,092,725Loxapine in newly admitted chronic schizophrenic patients.J Clin Pharmacol1975https://conductscience.org/library/papers/1092725PubMed
105,048,301Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.Clin Sci1972https://conductscience.org/library/papers/5048301PubMed
1114,141,840DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS.J Chronic Dis1964https://conductscience.org/library/papers/14141840PubMed
134,917,090Molindone in chronic schizophrenia.Clin Pharmacol Ther1970https://conductscience.org/library/papers/4917090PubMed
148,025Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.Arch Gen Psychiatry1976https://conductscience.org/library/papers/8025PubMed
154,374,155Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.Arch Gen Psychiatry1974https://conductscience.org/library/papers/4374155PubMed
164,869,439A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.Am J Psychiatry1968https://conductscience.org/library/papers/4869439PubMed
1714,089,354PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP.Arch Gen Psychiatry1964https://conductscience.org/library/papers/14089354PubMed
18809,232Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.Curr Ther Res Clin Exp1975https://conductscience.org/library/papers/809232PubMed
194,601,554Trifluoperazine: a comparison between regular and high doses.Psychopharmacologia1974https://conductscience.org/library/papers/4601554PubMed
204,631,378Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.Curr Ther Res Clin Exp1973https://conductscience.org/library/papers/4631378PubMed
214,917,354Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study.J Clin Pharmacol J New Drugs1970https://conductscience.org/library/papers/4917354PubMed

See all 65 references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
32,152,472Hippocampal subfield transcriptome analysis in schizophrenia psychosis.Mol Psychiatry2021https://conductscience.org/library/papers/32152472PubMed
30,572,373Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30572373PubMed
30,480,760Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30480760PubMed
27,078,222Risperidone (depot) for schizophrenia.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27078222PubMed
25,760,334Drug repurposing for the treatment of staphylococcal infections.Curr Pharm Des2015https://conductscience.org/library/papers/25760334PubMed
24,644,460Early onset priapism under chlorpromazine and risperidone therapy.Iran J Psychiatry Behav Sci2011https://conductscience.org/library/papers/24644460PubMed
22,513,966Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22513966PubMed
22,345,836A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia.Indian J Psychol Med2011https://conductscience.org/library/papers/22345836PubMed
22,034,474Treatment of the special patient with schizophrenia.Dialogues Clin Neurosci2001https://conductscience.org/library/papers/22034474PubMed
22,034,144Treatment-refractory schizophrenia.Dialogues Clin Neurosci2004https://conductscience.org/library/papers/22034144PubMed
21,279,034Reducing the number of anticonvulsant drugs taken by severely retarded epileptic patients.Can Fam Physician1984https://conductscience.org/library/papers/21279034PubMed
20,531,374Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia.Pharmacogenomics J2011https://conductscience.org/library/papers/20531374PubMed
20,021,320Effect of second-generation antipsychotics on cognition: current issues and future challenges.Expert Rev Neurother2010https://conductscience.org/library/papers/20021320PubMed
18,646,161Aripiprazole versus typical antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev2008https://conductscience.org/library/papers/18646161PubMed
17,253,464Depot fluspirilene for schizophrenia.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17253464PubMed
16,625,607Aripiprazole for schizophrenia.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/16625607PubMed
10,796,543Risperidone versus typical antipsychotic medication for schizophrenia.Cochrane Database Syst Rev2000https://conductscience.org/library/papers/10796543PubMed
6,808,540Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6808540PubMed
6,110,534Psychotherapeutic drugs: important adverse reactions and interactions.Drugs1980https://conductscience.org/library/papers/6110534PubMed
2,292,234Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.Drugs1990https://conductscience.org/library/papers/2292234PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21069

GET https://conductscience.org/api/papers/v1/21069/references?page=2